エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/02/18 | 4,335 | 4,384 | 4,293 | 4,372 | +12 | +0.3% | 760,400 |
| 2025/02/17 | 4,373 | 4,389 | 4,347 | 4,360 | -5 | -0.1% | 656,300 |
| 2025/02/14 | 4,413 | 4,428 | 4,330 | 4,365 | -54 | -1.2% | 1,044,400 |
| 2025/02/13 | 4,402 | 4,485 | 4,402 | 4,419 | +110 | +2.6% | 1,315,300 |
| 2025/02/12 | 4,445 | 4,449 | 4,305 | 4,309 | -143 | -3.2% | 1,878,300 |
| 2025/02/10 | 4,502 | 4,542 | 4,370 | 4,452 | -54 | -1.2% | 1,519,500 |
| 2025/02/07 | 4,467 | 4,674 | 4,448 | 4,506 | +5 | +0.1% | 2,537,600 |
| 2025/02/06 | 4,391 | 4,512 | 4,391 | 4,501 | +124 | +2.8% | 1,124,200 |
| 2025/02/05 | 4,419 | 4,430 | 4,352 | 4,377 | -79 | -1.8% | 1,193,000 |
| 2025/02/04 | 4,492 | 4,516 | 4,448 | 4,456 | +32 | +0.7% | 984,400 |
| 2025/02/03 | 4,455 | 4,463 | 4,392 | 4,424 | -197 | -4.3% | 2,048,300 |
| 2025/01/31 | 4,646 | 4,652 | 4,609 | 4,621 | -14 | -0.3% | 1,275,000 |
| 2025/01/30 | 4,601 | 4,645 | 4,594 | 4,635 | +4 | +0.1% | 1,134,000 |
| 2025/01/29 | 4,710 | 4,715 | 4,601 | 4,631 | -78 | -1.7% | 1,629,500 |
| 2025/01/28 | 4,679 | 4,733 | 4,667 | 4,709 | +33 | +0.7% | 1,875,300 |
| 2025/01/27 | 4,629 | 4,696 | 4,615 | 4,676 | +148 | +3.3% | 2,448,300 |
| 2025/01/24 | 4,506 | 4,573 | 4,491 | 4,528 | +42 | +0.9% | 1,914,600 |
| 2025/01/23 | 4,403 | 4,523 | 4,399 | 4,486 | +65 | +1.5% | 1,803,300 |
| 2025/01/22 | 4,350 | 4,438 | 4,343 | 4,421 | +162 | +3.8% | 1,969,200 |
| 2025/01/21 | 4,256 | 4,276 | 4,239 | 4,259 | +33 | +0.8% | 621,100 |
| 2025/01/20 | 4,251 | 4,275 | 4,226 | 4,226 | -14 | -0.3% | 574,000 |
| 2025/01/17 | 4,220 | 4,252 | 4,195 | 4,240 | +18 | +0.4% | 978,700 |
| 2025/01/16 | 4,250 | 4,312 | 4,222 | 4,222 | +10 | +0.2% | 1,410,500 |
| 2025/01/15 | 4,297 | 4,310 | 4,207 | 4,212 | -71 | -1.7% | 1,233,000 |
| 2025/01/14 | 4,248 | 4,287 | 4,221 | 4,283 | +24 | +0.6% | 1,576,000 |
| 2025/01/10 | 4,382 | 4,395 | 4,257 | 4,259 | -116 | -2.7% | 1,658,800 |
| 2025/01/09 | 4,350 | 4,380 | 4,323 | 4,375 | +17 | +0.4% | 1,174,600 |
| 2025/01/08 | 4,425 | 4,441 | 4,352 | 4,358 | -56 | -1.3% | 1,199,900 |
| 2025/01/07 | 4,390 | 4,433 | 4,352 | 4,414 | +43 | +1% | 1,443,900 |
| 2025/01/06 | 4,339 | 4,376 | 4,306 | 4,371 | +42 | +1% | 1,536,400 |
| 2024/12/30 | 4,326 | 4,387 | 4,302 | 4,329 | -26 | -0.6% | 1,372,300 |
| 2024/12/27 | 4,274 | 4,364 | 4,270 | 4,355 | +131 | +3.1% | 2,340,700 |
| 2024/12/26 | 4,274 | 4,293 | 4,221 | 4,224 | -53 | -1.2% | 3,239,400 |
| 2024/12/25 | 4,268 | 4,281 | 4,238 | 4,277 | +19 | +0.4% | 1,189,000 |
| 2024/12/24 | 4,275 | 4,334 | 4,257 | 4,258 | -15 | -0.4% | 2,006,900 |
| 2024/12/23 | 4,324 | 4,325 | 4,242 | 4,273 | -43 | -1% | 1,403,900 |
| 2024/12/20 | 4,360 | 4,391 | 4,316 | 4,316 | -23 | -0.5% | 2,114,400 |
| 2024/12/19 | 4,331 | 4,370 | 4,328 | 4,339 | -11 | -0.3% | 1,149,400 |
| 2024/12/18 | 4,380 | 4,382 | 4,334 | 4,350 | +5 | +0.1% | 998,000 |
| 2024/12/17 | 4,325 | 4,370 | 4,318 | 4,345 | -3 | -0.1% | 1,065,300 |
| 2024/12/16 | 4,385 | 4,388 | 4,323 | 4,348 | -33 | -0.8% | 1,022,900 |
| 2024/12/13 | 4,370 | 4,416 | 4,357 | 4,381 | -59 | -1.3% | 1,983,300 |
| 2024/12/12 | 4,441 | 4,488 | 4,417 | 4,440 | +5 | +0.1% | 1,464,500 |
| 2024/12/11 | 4,428 | 4,458 | 4,396 | 4,435 | +17 | +0.4% | 1,275,300 |
| 2024/12/10 | 4,495 | 4,501 | 4,402 | 4,418 | -52 | -1.2% | 1,721,900 |
| 2024/12/09 | 4,474 | 4,523 | 4,442 | 4,470 | +8 | +0.2% | 2,215,900 |
| 2024/12/06 | 4,452 | 4,485 | 4,441 | 4,462 | +10 | +0.2% | 1,324,000 |
| 2024/12/05 | 4,555 | 4,558 | 4,440 | 4,452 | -62 | -1.4% | 1,617,200 |
| 2024/12/04 | 4,581 | 4,581 | 4,392 | 4,514 | -165 | -3.5% | 2,844,600 |
| 2024/12/03 | 4,650 | 4,693 | 4,640 | 4,679 | +38 | +0.8% | 1,131,700 |
51～
100
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 427,100円 | +1.7% | -2.9% | 3.75% | 28.02倍 | 1.47倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 219,100円 | -3.5% | -11.3% | 2.74% | 20.12倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 166,700円 | -3.1% | -63.4% | 4.80% | 15.66倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
